E
Cytosorbents Corporation CTSO
$1.10 -$0.03-2.66%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 74.61% 32.67% 13.21% -661.64% 24.65%
Total Depreciation and Amortization -7.31% -2.38% 41.10% 184.43% 66.64%
Total Amortization of Deferred Charges -- 0.00% 0.00% -- --
Total Other Non-Cash Items -160.23% 40,839.02% 350.08% 53.62% -26.98%
Change in Net Operating Assets 660.64% -124.68% -140.88% 104.25% -71.64%
Cash from Operations 52.73% 30.85% -55.39% -19.98% 22.70%
Capital Expenditure -6.53% -108.69% 91.13% 55.25% 77.74%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -27.15% -46.82% 52.77% -645.95% -50.13%
Cash from Investing -15.79% -185.46% 81.40% 34.06% 64.03%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -100.00% -92.23% -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -115.27% 956.23% -183.56% 144.21% --
Foreign Exchange rate Adjustments 268.83% -99.43% -45.79% -171.09% 114.39%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 42.13% 182.25% -78.37% 1,465.86% 37.04%
Weiss Ratings